Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;75(6):921–927. doi: 10.1038/bjc.1997.162

Extramedullary plasmacytoma of the head and neck region: clinicopathological correlation in 25 cases.

S S Susnerwala 1, J H Shanks 1, S S Banerjee 1, J H Scarffe 1, W T Farrington 1, N J Slevin 1
PMCID: PMC2063399  PMID: 9062417

Abstract

Extramedullary plasmacytomas (EMP) of head and neck are rare tumours. Between 1972 and 1993, 25 cases of EMP of head and neck were seen at our institute. The clinical and pathological features and response to treatment are presented. At initial presentation, 23 (92%) patients presented with disease confined to a single extramedullary site only and two patients had in addition clinical involvement of cervical lymph nodes. All except these two patients received radiotherapy to the primary site only as initial treatment. Initial primary control of local disease was obtained in 16 of 24 (67%) patients treated with radical intent. With salvage treatment of further radiotherapy and/or chemotherapy, local disease control was achieved in 21 of 24 (88%) patients. One patient was treated with palliative intent. Conversion to multiple myeloma was seen in two patients (8%). Pathologically, the tumours were classified into low, intermediate and high grade, which correlated closely with outcome. This classification has been used for the first time in extramedullary plasmacytomas and is based on the multiple myeloma grading criteria devised by Bartl et al (1987). Fifteen of eighteen (83%) low-grade tumours and only one of six (17%) intermediate- and high-grade tumours were locally controlled after primary radiotherapy. This is statistically significant for local control (P= 0.0019) but not for overall survival (P= 0.12). The median survival and 5-year overall survival is 68 months and 58.9% respectively. We recommend consideration of adjuvant chemotherapy in patients with higher grade disease.

Full text

PDF
921

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartl R., Frisch B., Fateh-Moghadam A., Kettner G., Jaeger K., Sommerfeld W. Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. Am J Clin Pathol. 1987 Mar;87(3):342–355. doi: 10.1093/ajcp/87.3.342. [DOI] [PubMed] [Google Scholar]
  2. Corwin J., Lindberg R. D. Solitary plasmacytoma of bone vs. extramedullary plasmacytoma and their relationship to multiple myeloma. Cancer. 1979 Mar;43(3):1007–1013. doi: 10.1002/1097-0142(197903)43:3<1007::aid-cncr2820430333>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  3. Fermand J. P., Ravaud P., Chevret S., Leblond V., Divine M., Dreyfus F., Belanger C., Troussard X., Mariette X., Brouet J. C. High-dose therapy and autologous blood stem cell transplantation in multiple myeloma: preliminary results of a randomized trial involving 167 patients. Stem Cells. 1995 Aug;13 (Suppl 2):156–159. doi: 10.1002/stem.5530130725. [DOI] [PubMed] [Google Scholar]
  4. Greenberg P., Parker R. G., Fu Y. S., Abemayor E. The treatment of solitary plasmacytoma of bone and extramedullary plasmacytoma. Am J Clin Oncol. 1987 Jun;10(3):199–204. doi: 10.1097/00000421-198706000-00004. [DOI] [PubMed] [Google Scholar]
  5. Gromer R. C., Duvall A. J., 3rd Plasmacytoma of the head and neck. J Laryngol Otol. 1973 Sep;87(9):861–872. doi: 10.1017/s0022215100077732. [DOI] [PubMed] [Google Scholar]
  6. Guida M., Casamassima A., Abbate I., Paradiso A., Zito A., Marzullo F., Lorusso V., Timurian A., Cramarossa A., De Lena M. Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different nosological entities? Tumori. 1994 Oct 31;80(5):370–377. doi: 10.1177/030089169408000512. [DOI] [PubMed] [Google Scholar]
  7. Harwood A. R., Knowling M. A., Bergsagel D. E. Radiotherapy of extramedullary plasmacytoma of the head and neck. Clin Radiol. 1981 Jan;32(1):31–36. doi: 10.1016/s0009-9260(81)80242-5. [DOI] [PubMed] [Google Scholar]
  8. Holland J., Trenkner D. A., Wasserman T. H., Fineberg B. Plasmacytoma. Treatment results and conversion to myeloma. Cancer. 1992 Mar 15;69(6):1513–1517. doi: 10.1002/1097-0142(19920315)69:6<1513::aid-cncr2820690633>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  9. Kapadia S. B., Desai U., Cheng V. S. Extramedullary plasmacytoma of the head and neck. A clinicopathologic study of 20 cases. Medicine (Baltimore) 1982 Sep;61(5):317–329. doi: 10.1097/00005792-198209000-00004. [DOI] [PubMed] [Google Scholar]
  10. Knowling M. A., Harwood A. R., Bergsagel D. E. Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J Clin Oncol. 1983 Apr;1(4):255–262. doi: 10.1200/JCO.1983.1.4.255. [DOI] [PubMed] [Google Scholar]
  11. Kotner L. M., Wang C. C. Plasmacytoma of the upper air and food passages. Cancer. 1972 Aug;30(2):414–418. doi: 10.1002/1097-0142(197208)30:2<414::aid-cncr2820300217>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  12. Mayr N. A., Wen B. C., Hussey D. H., Burns C. P., Staples J. J., Doornbos J. F., Vigliotti A. P. The role of radiation therapy in the treatment of solitary plasmacytomas. Radiother Oncol. 1990 Apr;17(4):293–303. doi: 10.1016/0167-8140(90)90003-f. [DOI] [PubMed] [Google Scholar]
  13. Mendenhall C. M., Thar T. L., Million R. R. Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys. 1980 Nov;6(11):1497–1501. doi: 10.1016/0360-3016(80)90006-1. [DOI] [PubMed] [Google Scholar]
  14. Mock P. M., Neal G. D., Aufdemorte T. B. Immunoperoxidase characterization of extramedullary plasmacytoma of the head and neck. Head Neck Surg. 1987 Jul-Aug;9(6):356–361. doi: 10.1002/hed.2890090610. [DOI] [PubMed] [Google Scholar]
  15. Pahor A. L. Extramedullary plasmacytoma of the head and neck, parotid and submandibular salivary glands. J Laryngol Otol. 1977 Mar;91(3):241–258. doi: 10.1017/s0022215100083626. [DOI] [PubMed] [Google Scholar]
  16. Rainer E. H. Extramedullary plasmacytoma of upper respiratory tract. J Laryngol Otol. 1970 Sep;84(9):909–919. doi: 10.1017/s0022215100072686. [DOI] [PubMed] [Google Scholar]
  17. Shih L. Y., Dunn P., Leung W. M., Chen W. J., Wang P. N. Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone. Br J Cancer. 1995 Jan;71(1):128–133. doi: 10.1038/bjc.1995.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Soesan M., Paccagnella A., Chiarion-Sileni V., Salvagno L., Fornasiero A., Sotti G., Zorat P. L., Favaretto A., Fiorentino M. Extramedullary plasmacytoma: clinical behaviour and response to treatment. Ann Oncol. 1992 Jan;3(1):51–57. doi: 10.1093/oxfordjournals.annonc.a058070. [DOI] [PubMed] [Google Scholar]
  19. Todd I. D. Treatment of solitary plasmocytoma. Clin Radiol. 1965 Oct;16(4):395–399. doi: 10.1016/s0009-9260(65)80088-5. [DOI] [PubMed] [Google Scholar]
  20. Wiltshaw E. Chemotherapy in the management of extramedullary plasmacytoma. Cancer Chemother Pharmacol. 1978;1(3):167–175. doi: 10.1007/BF00253117. [DOI] [PubMed] [Google Scholar]
  21. Wiltshaw E. The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis. Medicine (Baltimore) 1976 May;55(3):217–238. doi: 10.1097/00005792-197605000-00002. [DOI] [PubMed] [Google Scholar]
  22. Woodruff R. K., Whittle J. M., Malpas J. S. Solitary plasmacytoma. I: Extramedullary soft tissue plasmacytoma. Cancer. 1979 Jun;43(6):2340–2343. doi: 10.1002/1097-0142(197906)43:6<2340::aid-cncr2820430625>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES